Inventor · disambiguated record
Sushant Malhotra
Also filed as: MALHOTRA SUSHANT
21 granted patents·10 pending applications·79 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
31 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0290US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0389US11236068B2Fused ring compoundsGENENTECH INC·Filed 2019·Granted Feb 1, 2022·12 cites·40 claims
- 0489US10385058B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2017·Granted Aug 20, 2019·3 cites·54 claims
- 0588US10882864B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2019·Granted Jan 5, 2021·3 cites·24 claims
- 0687US7511056B2TGF-β inhibitorsLILLY CO ELI·Filed 2005·Granted Mar 31, 2009·12 cites·4 claims
- 0784US11661424B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2020·Granted May 30, 2023·1 cites·11 claims
- 0883US8022065B2Purine derivatives as kinase inhibitorsLILLY CO ELI·Filed 2008·Granted Sep 20, 2011·4 cites·10 claims
- 0981US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1078US2023250103A1Process for preparing btk inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1178US2025059163A1Fused ring compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1277US7405299B2Compounds as pharmaceutical agentsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·15 cites·1 claims
- 1375US8058425B2Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Granted Nov 15, 2011·5 cites·8 claims
- 1475US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1572US2025042919A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1669US12084429B2Fused ring compoundsGENENTECH INC·Filed 2021·Granted Sep 10, 2024·0 cites·15 claims
- 1769US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 1869US7109229B2Methods and compounds for treating proliferative diseasesLILLY CO ELI·Filed 2001·Granted Sep 19, 2006·7 cites·8 claims
- 1967US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 2064US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 2163US9303043B2Process for making benzoxazepin compoundsGENENTECH INC·Filed 2014·Granted Apr 5, 2016·1 cites·10 claims
- 2262US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2362US2022281893A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 2454US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 2554US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 2653US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 2753US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 2853US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 2951US11760744B2Fused ring compoundsGENENTECH INC·Filed 2019·Granted Sep 19, 2023·0 cites·28 claims
- 3047US2011294792A1Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Application pending·0 cites
- 3136US2016311817A1HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORSGENENTECH INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →